アルコールおよび物質使用障害

Alcohol and drug problems affect more than 20 million people in the United States. Beacon Health Options (Beacon) is committed to the early identification and treatment of alcohol and other drug use disorders to promote optimal health for its members. To that help with that goal, we want to work with providers to identify all members with alcohol and other drug disorders and to increase the number of those members identified who get access to the SUD services they need.

Healthcare Effectiveness Data and Information Set (HEDIS®)¹ Tip Sheets

• Follow-up after ED Visit for Alcohol/ Drug Abuse or Dependence
• Follow-up After High Intensity Care for Substance Abuse Disorder
• Use of Opioids at High Dosages
• Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence
• Pharmacotherapy for Opioid Use Disorder
• Use of Opioids from Multiple Providers

会員資料

• Do I Have Substance Use Disorder?
• アルコール使用アンケート
• 鎮痛剤に問題がありますか？

スクリーニングツール

• 同時発生するメンタルヘルスと物質使用障害のスクリーニング
• CRAFFTプロバイダー
• National Institute on Alcohol Abuse and Alcoholism Pocket Guide for Alcohol Screening and Brief Intervention
• AUDIT-PCスクリーニングツール
• アルコールスケールの臨床研究所離脱評価（CIWA-Ar）
• アルコール離脱重症度スケール（PAWSS）の予測
  
  The Prediction of Alcohol Withdrawal Severity Scale (PAWSS) has good validity among medically ill hospitalized patients, helping clinicians identify those at risk for complicated alcohol withdrawal syndromes, such as seizures or delirium tremens (DT); it is not a measure of current withdrawal intensity. The PAWSS is copyrighted, but the author has authorized Beacon to post as a clinical and/or research resource. Authorization to use for any other purpose would require permission from Dr. Maldonado.
  
  参照：
  Maldonado、JR、Y。Sher、S。Das、K。Hills-Evans、A。Frenklach、S。Lolak、R。Talley、E。Neri（2015） 「医学的に病気の入院患者におけるアルコール離脱重症度スケール（PAWSS）の予測の前向き検証研究：複雑なアルコール離脱症候群の予測のための新しいスケール。」 アルコールとアルコール依存症 50(5): 509-518.

¹ HEDIS is a registered trademark of the National Committee for Quality Assurance (NCQA).